INTRODUCTION: For many infectious diseases, women are at higher risk and have a more severe disease course than men for many reasons, including biological differences, social inequalities, and restrictive cultural norms. The study focuses on infections with human papillomaviruses (HPV) in the form of cervical cancer as a gender-specific disease. The main goal is to evaluate cervical tumour incidence trends in the Czech female population in the HPV vaccination period 2012-2020 in relation to selected demographic, socioeconomic, and geographic indicators. METHODS: This is a retrospective ecological study. Data from publicly available databases about the incidence and mortality of cervical tumours (C53 Malignant neoplasm of cervix uteri, D06 Carcinoma in situ of cervix uteri according to ICD 10) and HPV vaccination rate were analysed and compared with demographic, socioeconomic and territorial data. Associations were searched using correlation analysis. RESULTS: There was a decreasing trend in the incidence of cervical cancer in the observed period. Regarding cervical tumours (C53, D06) and malignant neoplasm of cervix uteri incidence (C53), the decrease was approximately 11 and 20%, respectively. Differences between regions were observed in incidences and vaccination rates. Based on correlation analysis, indicators connected with urban/rural aspects, such as a share of urban population and population density, were statistically significant. The indicators related to higher cervical cancer incidence are the high unemployment rate of women, the high number of divorces, the high number of abortions, the high share of the urban population, the high number of students, and the high number of women with only primary education. On the other hand, the indicators related to lower cervical cancer incidence are the high gross domestic product (GDP), the high average gross monthly wage per employee, the high employment rate of women, the higher average age of mothers at birth, and the high number of women with tertiary education. CONCLUSION: Results underline the problem of economically disadvantaged regions and families. Increasing vaccination rates, promoting regular screening for cervical cancer, and supporting awareness in the population, especially in regions with higher incidence rates, should be priorities for public health efforts.

Department of Healthcare Management and Public Health Faculty of Health Sciences Palacký University Olomouc Olomouc Czechia

Department of Humanities and Social Sciences Faculty of Health Sciences Palacký University Olomouc Olomouc Czechia

Department of Preclinical Subjects Faculty of Health Sciences Palacký University Olomouc Olomouc Czechia

Science and Research Centre Faculty of Health Sciences Palacký University Olomouc Olomouc Czechia

See more in PubMed

Vlassoff C, Manderson L. Incorporating gender in the anthropology of infectious diseases. Trop Med Int Health. (1998) 3:1011–9. doi: 10.1111/j.1365-3156.1998.tb00001.x PubMed DOI

Straif-Bourgeois S, Ratard R, Kretzschmar M. Infectious disease epidemiology In: Ahrens W, Pigeot I, editors. Handbook of epidemiology. New York, NY: Springer New York; (2014). 2041–119.

Gerberding JL. Women and infectious diseases. Emerg Infect Dis. (2004) 10:1965–7. doi: 10.3201/eid1011.040800, PMID: PubMed DOI PMC

Mege J-L, Bretelle F, Leone M. Sex and bacterial infectious diseases. New Microbes New Infect. (2018) 26:S100–3. doi: 10.1016/j.nmni.2018.05.010, PMID: PubMed DOI PMC

Gay L, Melenotte C, Lakbar I, Mezouar S, Devaux C, Raoult D, et al. . Sexual dimorphism and gender in infectious diseases. Front Immunol. (2021) 12:12. doi: 10.3389/fimmu.2021.698121, PMID: PubMed DOI PMC

Sappenfield E, Jamieson DJ, Kourtis AP. Pregnancy and susceptibility to infectious diseases. Infect Dis Obstet Gynecol. (2013) 2013:1–8. doi: 10.1155/2013/752852, PMID: PubMed DOI PMC

Buskwofie A, David-West G, Clare CA. A review of cervical Cancer: incidence and disparities. J Natl Med Assoc. (2020) 112:229–32. doi: 10.1016/j.jnma.2020.03.002 PubMed DOI

Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. (2000) 151:1158–71. doi: 10.1093/oxfordjournals.aje.a010166 PubMed DOI

Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. (2003) 16:1–17. doi: 10.1128/CMR.16.1.1-17.2003, PMID: PubMed DOI PMC

Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. (2020) 40:602–8. doi: 10.1080/01443615.2019.1634030, PMID: PubMed DOI PMC

World Health Organization . Fact sheet: Cervical cancer. (2022). Available at: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer (Accessed May 19, 2023).

Falcaro M, Castañon A, Ndlela B, Checchi M, Soldan K, Lopez-Bernal J, et al. . The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Lancet. (2021) 398:2084–92. doi: 10.1016/S0140-6736(21)02178-4, PMID: PubMed DOI

Harder T, Wichmann O, Klug SJ, van der Sande MAB, Wiese-Posselt M. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review. BMC Med. (2018) 16:110. doi: 10.1186/s12916-018-1098-3, PMID: PubMed DOI PMC

Giannone G, Giuliano AR, Bandini M, Marandino L, Raggi D, Earle W, et al. . HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverage. Cancer Treat Rev. (2022) 111:102467. doi: 10.1016/j.ctrv.2022.102467 PubMed DOI

World Health Organization . COVID-19 pandemic fuels largest continued backslide in vaccinations in three decades. (2022). Available at: https://www.who.int/news/item/15-07-2022-covid-19-pandemic-fuels-largest-continued-backslide-in-vaccinations-in-three-decades (Accessed February 15, 2023).

Kapoor CS, Sharma M. Prevalence of HPV infection in reproductive aged female in Delhi NCR region. Clin Epidemiology Glob Health. (2020) 8:612–5. doi: 10.1016/j.cegh.2019.12.012 DOI

Lin W, Chen B, Hu H, Yuan S, Wu B, Zhong C, et al. . Joint effects of HPV-related knowledge and socio-demographic factors on HPV testing behaviour among females in Shenzhen. Eur J Pub Health. (2021) 31:582–8. doi: 10.1093/eurpub/ckab049, PMID: PubMed DOI

Lei T, W-min M, T-hai L, L-qiong D, Fang L, W-qing C, et al. . Incidence and mortality trend of cervical cancer in 11 cancer registries of China. Chin. J Cancer Res. (2011) 23:10–4. doi: 10.1007/s11670-011-0010-x, PMID: PubMed DOI PMC

Tran NK, Park Y, Kim B, Oh J, Ki M. Incidence and mortality of cervical cancer in Vietnam and South Korea (1999-2017). Epidemiology Health. (2020) 42:e2020075. doi: 10.4178/epih.e2020075, PMID: PubMed DOI PMC

Tachezy R, Smahelova J, Salakova M, Arbyn M, Rob L, Skapa P, et al. . Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV. PLoS One. (2011) 6:6. doi: 10.1371/journal.pone.0021913, PMID: PubMed DOI PMC

Institute of Health Information and Statistics of the Czech Republic. National Screening Center . Vaccination of girls and boys against human papillomaviruses (HPV) prevents the occurrence of a number of serious cancers and protects human lives. (2018). Available at: https://nsc.uzis.cz/news-detail/cs/29-ockovani-divek-i-chlapcu-proti-lidskym-papilomavirum-hpv-zabranuje-vzniku-rady-vaznych-nadorovych-onemocneni-a-chrani-lidske-zivoty/ (Accessed February 10, 2023).

Martakis K, Alexander D, Schloemer T, Blair M, Rigby M, Schröder-Bäck P. Human papillomavirus vaccination and respect for children’s developing autonomy: results from a European Union wide study. J Child Health Care. (2018) 23:343–57. doi: 10.1177/1367493519852476, PMID: PubMed DOI PMC

Tachezy R, Šmahelová J. Why to vaccinate boys against papillomaviruses? Pediatrie pro praxis. (2021) 22:263–7. doi: 10.36290/ped.2021.054 DOI

Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, et al. . ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Czechia. (2022). Available at: https://hpvcentre.net/statistics/reports/CZE.pdf (Accessed February 10, 2023).

ICO/IARC Information Centre on HPV and Cancer . Czechia. Human Papillomavirus and Related Cancers, Fact Sheet 2023. (2023). Available at: https://hpvcentre.net/statistics/reports/CZE_FS.pdf (Accessed November 20, 2023)

Czech Statistical Office . Focus on Women and Men – 2022. (2022). Available at: https://www.czso.cz/csu/czso/focus-on-women-and-men-2022 (Accessed February 13, 2023).

Institute of Health Information and Statistics of the Czech Republic . Czech health statistics 2019. (2020). Available at: https://www.uzis.cz/res/f/008381/zdrroccz2019.pdf (Accessed February 13, 2023).

Dušek L, Mužík J, Kubásek M, Koptíková J, Žaloudík J, Vyzula R. Epidemiology of malignant tumors in the Czech Republic. Masarykova univerzita. (2005). Available at: http://www.svod.cz. (Accessed February 10, 2023).

Czech Statistical Office . Age Distribution of the Population – 2021. (2022). Available at: https://www.czso.cz/csu/czso/age-distribution-of-the-population-2021 (Accessed February 13, 2023).

Czech Statistical Office . Interregional comparison of selected indicators. (2023). Available at: https://www.czso.cz/csu/xm/mezikrajske_srovnani_vybranych_ukazatelu (Accessed February 13, 2023).

Czech Statistical Office . Public database. (2023). Available at: https://vdb.czso.cz/vdbvo2/faces/en/index.jsf?page=uziv-dotaz (Accessed February 13, 2023)

State Administration of Land Surveying and Cadastre . Geoportal. (2010). Available at: https://geoportal.cuzk.cz/(S(gbqevdvghr43bw5iyj41kpss))/Default.aspx?lng=EN&menu=2291&mode=TextMeta&side=mapy_data200&metadataID=CZ-CUZK-DATA200-HRANICE-V (Accessed February 13, 2023).

World Health Organization . Uzbekistan achieves high HPV vaccination coverage against cervical cancer. (2022). Available at: https://www.who.int/europe/news/item/07-09-2022-uzbekistan-achieves-high-hpv-vaccination-coverage-against-cervical-cancer (Accessed May 15, 2023).

Colzani E, Johansen K, Johnson H, Pastore CL. Human papillomavirus vaccination in the European Union/European economic area and globally: a moral dilemma. Eur Secur. (2021) 26:26. doi: 10.2807/1560-7917.ES.2021.26.50.2001659, PMID: PubMed DOI PMC

European Centre for Disease Prevention and Control . Human papillomavirus infection: recommended vaccinations. Stockholm. (2020). Available at: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=38&SelectedCountryIdByDisease=-1 (Accessed May 15, 2023).

Guzzetta G, Faustini L, Panatto D, Gasparini R, Manfredi P, Liu X. The impact of HPV female immunization in Italy: model based predictions. PLoS One. (2014) 9:e91698. doi: 10.1371/journal.pone.0091698 PubMed DOI PMC

Kurosawa M, Sekine M, Yamaguchi M, Kudo R, Hanley SJB, Hara M, et al. . Long-term effects of human papillomavirus vaccination in clinical trials and real-world data: a systematic review. Vaccines. (2022) 10:256. doi: 10.3390/vaccines10020256, PMID: PubMed DOI PMC

Brunner-Ziegler S, Rieder A, Stein KV, Koppensteiner R, Hoffmann K, Dorner TE. Predictors of participation in preventive health examinations in Austria. BMC Public Health. (2013) 13:1–9. doi: 10.1186/1471-2458-13-1138, PMID: PubMed DOI PMC

Janßen C, Sauter S, Kowalski C. The influence of social determinants on the use of prevention and health promotion services: results of a systematic literature review. Psychosoc Med. (2012) 9:Doc07. doi: 10.3205/psm000085 PubMed DOI PMC

Czech Statistical Office . Statistical Atlas. 2021 Population and housing census (2023). Available at: https://geodata.statistika.cz/as/atlas/?xmax=2373511.252155472&ymax=6751045.634670809&xmin=1076785.5153144835&ymin=6079019.887840807&wkid=102100&ds=1 (Accessed Feb 28, 2024).

Jentschke M, Kampers J, Becker J, Sibbertsen P, Hillemanns P. Prophylactic HPV vaccination after conization: a systematic review and meta-analysis. Vaccine. (2020) 38:6402–9. doi: 10.1016/j.vaccine.2020.07.055, PMID: PubMed DOI

Sundaram N, Voo TC, Tam CC. Adolescent HPV vaccination: empowerment, equity and ethics. Hum Vaccin Immunother. (2020) 16:1835–40. doi: 10.1080/21645515.2019.1697596, PMID: PubMed DOI PMC

Finney Rutten LJ, Wilson PM, Jacobson DJ, Agunwamba AA, Radecki Breitkopf C, Jacobson RM, et al. . A population-based study of sociodemographic and geographic variation in HPV vaccination. Cancer Epidemiol Biomarkers Prev. (2017) 26:533–40. doi: 10.1158/1055-9965.EPI-16-0877, PMID: PubMed DOI PMC

Socioeconomic predictors of preventive health check-ups by a general practitioner in the Czech Republic